Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

Completed

Conditions studied: Obstructive Sleep Apnea

In brief

This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.

Key facts

Study ID

NCT03122483

Run by

Beckman Coulter, Inc.

People needed

250

Starts

2016-01-01

Expected to finish

2017-07-14

Last updated by the study team

2017-08-18

Who can join

Age: 18 and older, up to 70. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Written Informed Consent
• Male
• 18-70 years old
• Presentation with symptoms suggestive of obstructive sleep apnea
• Diagnostic sleep study
• Blood draw

You may not qualify if…

• Prior (within past year) or current therapy for sleep apnea
• Use of opioid pain medication, steroids or allopurinol (within past 30 days)
• Use of chronic anti-inflammatory drugs (within past 7 days)
• Active cancer under current treatment or monitoring

Where it is running

• Sleep Center Orange County — Irvine, California, United States
• Brigham and Women's Hospital — Boston, Massachusetts, United States
• SleepMed — Columbia, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.